[CIS PIDD] [cis-pidd] Yellow fever vaccine

[Mel.Berger at cslbehring.com]

Mike- havng heard of a number of cases of "viscerottophic" disease from the yellow fever vaccine, I have been afraid to give it to CVID patients. I do not know whether virus is excreted. Also, one of the tyhpoid vaccines is live, so I suppose there is Gi shedding.

Mel



On Dec 10, 2012, at 9:26 PM, "Michael Blaese" <mblaese at comcast.net<mailto:mblaese at comcast.net>> wrote:

Dear colleagues,

IDF has received the following inquiry from a caregiver for a patient with CVID.

 QUESTION: My daughter may be exposed to a person who is taking typhoid fever pills and a yellow fever shot for a trip to India. Is it necessary to avoid the person or how much contact with the person can be made safely?

Is there a risk of horizontal spread of yellow fever vaccine from a recently immunized individual to a patient with CVID?  The CDC recommendation is to not allow recently vaccinated individuals to donate blood for 2 weeks, but I have not been able to find information on the potential risk of horizontal spread from ordinary contact.  Does anyone have experience with the direct immunization of a CVID patient with the yellow fever vaccine causing significant problems for the patient?

Any information you can provide would be greatly appreciated.   Maybe someone from a yellow fever endemic area might have direct experience with this question that just does not come up very often in the northern U.S.

Thanks

R Michael Blaese,  MD
Immune Deficiency Foundation

---

The CIS-PIDD listserv is supported by:

[http://www.clinimmsoc.org/UserFiles/image/cis-pidd-list-logo_v1.jpg]
The science & practice of human immunology

P: +1.414.224.8095
E: <mailto:info at clinimmsoc.org> info at clinimmsoc.org<mailto:info at clinimmsoc.org>

Not a member of CIS? Please visit <https://cis.execinc.com/edibo/Signup> www.clinimmsoc.org<http://www.clinimmsoc.org> to join!

You are currently subscribed to cis-pidd as: <mailto:mel.berger at cslbehring.com> mel.berger at cslbehring.com<mailto:mel.berger at cslbehring.com>.
To unsubscribe click here: <http://lm.clinimmsoc.org/u?id=183824392.4a5e4b979d2e59f93eea8a6e1962edf8&n=T&l=cis-pidd&o=42338274> http://lm.clinimmsoc.org/u?id=183824392.4a5e4b979d2e59f93eea8a6e1962edf8&n=T&l=cis-pidd&o=42338274

This email, including any attachments, is confidential and contains proprietary content and may be legally privileged. This transmission is intended only for the designated recipient(s), and any duplication or distribution, in any form or part, without the written consent of the sender is strictly prohibited. These confidentiality protections apply even if you received this transmission in error, in which case you should delete the message, disregard its contents and notify the sender of the mistake. CSL Behring

---
The CIS-PIDD listserv is supported by the Clinical Immunology Society
The science & practice of human immunology

P: +1.414.224.8095
E: info at clinimmsoc.org

Not a member of CIS? Please visit www.clinimmsoc.org to join!

You are currently subscribed to cis-pidd as: pagid at list.clinimmsoc.org.
To unsubscribe click here: http://lm.clinimmsoc.org/u?id=183939985.3ea13d40a15475ac00ebbd9cd8a37d6d&n=T&l=cis-pidd&o=42339836
or send a blank email to leave-42339836-183939985.3ea13d40a15475ac00ebbd9cd8a37d6d at lists.clinimmsoc.org